Overview

The Study of Oral Fluorescite to Confirm the Authenticity of Point of Care Urine Samples

Status:
Completed
Trial end date:
2019-11-28
Target enrollment:
Participant gender:
Summary
During this study, participants will ingest 100 mg of fluorescein disodium or a placebo (no drug) mixed in GatoradeTM. Participants will then provide a urine sample after 10, 15, 20 or 30 minutes to see if the investigator can detect fluorescein fluorescence (light) in the urine.
Phase:
Phase 1
Details
Lead Sponsor:
UpTru Inc.
Collaborator:
Medicor Research Inc.